Skip to main content
GutCited
FIGURE 3 A, Duration on full treatment dose and B the changes in body weight are shown for all participants. B, The changes in body weight (kg) from the beginning of the study until the end of the triheptanoin treatment vs until the end of the full study
Figure 4. FIGURE 3 A, Duration on full treatment dose and B the changes in body weight are shown for all participants. B, The changes in body weight (kg) from the beginning of the study until the end of the triheptanoin treatment vs until the end of the full study (after downtitration and no add-on treatment for 4 wk) are shown for each participant. Please note that several participants lost some of the body weight gained at the end of the maintenance phase. C, The changes in seizure frequencies (number of seizures/28 d) from baseline vs maintenance treatment phases are shown. D,E There is no relationship of changes in seizure frequency vs the volume of triheptanoin taken (D) or the dose taken relative to body weight (E).

More Figures from This Paper

Figure 2

Figure 2
Figure 3

Figure 3

Figure 4

952 × 759px · 145,8 KB

Source Paper

Open-label long-term treatment of add-on triheptanoin in adults with drug-resistant epilepsy.

Epilepsia open (2020)

PMID: 32524048

DOI: 10.1002/epi4.12391

Cite This Figure

![Figure 4: FIGURE 3 A, Duration on full treatment dose and B the changes in body weight are shown for all participants. B, The changes in body weight (kg) from the beginning of the study until the end of the triheptanoin treatment vs until the end of the full study ](https://pdfs.citedhealth.com/figures/32524048/168.png)

> Source: Karin Borges et al. "Open-label long-term treatment of add-on triheptanoin in adults with drug-resist." *Epilepsia open*, 2020. PMID: [32524048](https://pubmed.ncbi.nlm.nih.gov/32524048/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/32524048/168.png" alt="FIGURE 3 A, Duration on full treatment dose and B the changes in body weight are shown for all participants. B, The changes in body weight (kg) from the beginning of the study until the end of the triheptanoin treatment vs until the end of the full study " />
  <figcaption>Figure 4. FIGURE 3 A, Duration on full treatment dose and B the changes in body weight are shown for all participants. B, The changes in body weight (kg) from the beginning of the study until the end of the triheptanoin treatment vs until the end of the full study <br>  Source: Karin Borges et al. "Open-label long-term treatment of add-on triheptanoin in adults with drug-resist." <em>Epilepsia open</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32524048/">32524048</a></figcaption>
</figure>

Bằng chứng liên quan

C
Medium-Chain Triglycerides (MCT Oil) cho Bloating and Intestinal Gas

Xếp hạng C · 3 nghiên cứu